We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.
Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


Thermo Fisher to Acquire Affymetrix, Strengthens Biosciences Leadership

Thermo Fisher Scientific and Affymetrix have announced that their boards of directors have unanimously approved Thermo Fisher’s acquisition of Affymetrix for USD 14.00 per share in cash, representing purchase price of approximately USD 1.3 billion  More...
12 Jan 2016

Joint Venture Formed to Commercialize CRISPR/Cas9 Gene-Editing Technology

An agreement has been signed creating a joint venture to enable biopharmaceutical partners to commercialize and explore new uses for CRISPR-Cas9 gene-editing technology.  More...
27 Dec 2015

Drug Development Agreement Targets Migraine Treatments

A British drug development company is teaming up with a major international pharmaceutical corporation to develop, commercialize, and manufacture treatments for migraine.  More...
13 Dec 2015

Japanese Stem Cell Firm Acquires Scottish Drug Discovery Support Company

In order to facilitate its move into the drug discovery industry, a Japanese stem cell technology company has acquired a Scottish biotechnology company that provides highly characterized human tissues for pharmaceutical development studies.  More...
06 Dec 2015

Pfizer to Buy Allergan in 160 Billion Dollar Deal

In the largest ever deal in the health care sector, Pfizer will buy Botox maker Allergan, in a deal worth USD 160 billion.   More...
06 Dec 2015

Gene Expression Informatics Companies Collaborate on Diagnostics of Age-Related Diseases

Affymetrix, Inc. and XRGenomics LTD have announced a partnership to collaborate on research and development of a new generation of diagnostic tests for age-related diseases.   More...
22 Nov 2015

Purchase of Biopharmaceutical Company Will Boost Development of Nitroxyl-Based Cardiovascular Disease Drugs

A major international biopharmaceutical company has announced the acquisition of a private biotech company that specializes in the development of drugs for treatment of cardiovascular disease.   More...
15 Nov 2015

BioResearch Industry News channel updates the reader on mergers and takeovers, on cooperative agreements and on trends in the biotech industry worldwide.
Copyright © 2000-2019 Globetech Media. All rights reserved.